Merck MRK
NYSE MRK
$152.55 +3.56 (+2.39%)
At close: Aug 21, 2026 · 4:01 PM EDT

Merck (MRK) Profit After Tax (2009 - 2026)

Merck (MRK) posted quarterly Profit After Tax of -$4.2 billion for Q1 2026, down 183.38% year-over-year from $5.1 billion in Q1 2025, and down 242.66% quarter-over-quarter from $3.0 billion in Q4 2025.

Merck (MRK) Profit After Tax (2009 - 2026) Analysis & Trends

Merck (MRK) has reported Profit After Tax for 18 consecutive years, with -$4.2 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Profit After Tax fell 183.38% year-over-year to -$4.2 billion; the TTM figure through Mar 2026 stood at $8.9 billion (down 48.73% YoY), while the FY2025 annual figure was $18.3 billion, up 6.6% from the prior year.
  • Profit After Tax slipped to -$4.2 billion in Q1 2026 per MRK's latest filing, from $3.0 billion in the prior quarter.
  • Across five years, Profit After Tax topped out at $5.8 billion in Q3 2025 and bottomed at -$6.0 billion in Q2 2023.
  • Historically, Profit After Tax has averaged $2.7 billion across 5 years, with a median of $3.7 billion in 2024.
  • Annual changes were most pronounced in 2023 — Profit After Tax tumbled 251.5% — and 2024, when it jumped 408.4%.
  • Merck's Profit After Tax stood at $3.0 billion in 2022, then sank by 140.24% to -$1.2 billion in 2023, then surged by 408.4% to $3.7 billion in 2024, then declined by 20.62% to $3.0 billion in 2025, then slumped by 242.66% to -$4.2 billion in 2026.
  • Business Quant data shows MRK's Profit After Tax at -$4.2 billion in Q1 2026, $3.0 billion in Q4 2025, and $5.8 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 5.53 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 3.62 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 3.26 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 2.51 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -10.50 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -248.00 Mn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 207.96 Mn
10 Sanofi 55.07 Bn 47.69 Bn 10.79 Bn 438.21 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.34 Bn
Mar 31, 2026 -4.24 Bn
Dec 31, 2025 2.97 Bn
Sep 30, 2025 5.79 Bn
Jun 30, 2025 4.43 Bn
Mar 31, 2025 5.09 Bn
Dec 31, 2024 3.74 Bn
Sep 30, 2024 3.16 Bn
Jun 30, 2024 5.46 Bn
Mar 31, 2024 4.76 Bn
Dec 31, 2023 -1.21 Bn
Sep 30, 2023 4.75 Bn
Jun 30, 2023 -5.98 Bn
Mar 31, 2023 2.82 Bn
Dec 31, 2022 3.02 Bn
Sep 30, 2022 3.25 Bn
Jun 30, 2022 3.94 Bn
Mar 31, 2022 4.31 Bn
Dec 31, 2021 4.52 Bn
Sep 30, 2021 4.57 Bn